Survival plots revealed a significant decrease in overall survival (OS) and disease-free survival (DFS) among tumor samples exhibiting elevated GOLM1 or B4GALT1 expression (n = 89) compared with those with low expression (n = 89). This evidence concerns the gene GOLM1 and neoplasm.